Ensysce Biosciences (ENSC) Price/Sales Ratio

Price: $3.89
Market Cap: $5.47M
Avg Volume: 71.13K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.648
52W Range: $2.115-14.67
Website: Ensysce Biosciences

What is Ensysce Biosciences's Price/Sales Ratio?

  • Ensysce Biosciences's trailing twelve month (TTM) Price/Sales ratio is 5.45.
  • Ensysce Biosciences's annual Price/Sales ratio as of today is 0.00.
  • Ensysce Biosciences's quarterly Price/Sales ratio is 0.00.

What is the Price/Sales Ratio?

The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.

How is the Price/Sales Ratio calculated?

The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:

P/S Ratio = Market Capitalization / Total Sales (Revenue)

Related Metrics

Other important metrics to assess Ensysce Biosciences's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: 0.00
    • Quarterly: 13.45
    • TTM: -4.85
  • P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
    • Annual: 0.00
    • Quarterly: 5.15
    • TTM: 5.57
  • P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: 0.00
    • Quarterly: -34.90
    • TTM: -4.50
  • PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
    • Annual: 0.00
    • Quarterly: -0.10
    • TTM: -0.16

These metrics provide insights into Ensysce Biosciences's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Price/Sales Ratio

0.00

Quarterly Price/Sales Ratio

0.00

TTM Price/Sales Ratio

5.45

Ensysce Biosciences Historical Price/Sales Ratio
2500.002500.002000.002000.001500.001500.001000.001000.00500.00500.000.000.00Price/Sales Ratio2018201820192019202020202021202120222022202320232024202420252025
Historical P/E Ratio
30000.0030000.000.000.00-30000.00-30000.00-60000.00-60000.00-90000.00-90000.00-120000.00-120000.00P/E Ratio2018201820192019202020202021202120222022202320232024202420252025
Historical P/B Ratio
100.00100.000.000.00-100.00-100.00-200.00-200.00-300.00-300.00-400.00-400.00-500.00-500.00P/B Ratio2018201820192019202020202021202120222022202320232024202420252025
Historical P/C Ratio
4000.004000.000.000.00-4000.00-4000.00-8000.00-8000.00-12000.00-12000.00-16000.00-16000.00P/C Ratio2018201820192019202020202021202120222022202320232024202420252025
Historical PEG Ratio
21.0021.0014.0014.007.007.000.000.00-7.00-7.00-14.00-14.00PEG Ratio2018201820192019202020202021202120222022202320232024202420252025

Ensysce Biosciences Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year Price/Sales Ratio P/E Ratio P/B Ratio P/C Ratio PEG Ratio
2024 0.00 0.00 0.00 0.00 0.00
2023 16.14 -3.39 -111.50 -3.34 0.04
2022 9.63 -0.97 -6.03 -1.36 0.02
2021 402.58 -48.78 -174.26 -172.48 -0.02
2020 748.16 -3133.17 -456.65 -2357.97 16.06
2019 2089.62 2496.69 19.80 335.25 -11.54
2018 0.00 -2738.64 18.63 -2969.59 -0.65
2017 0.00 -115727.89 18.49 -14334.61 0.00

Related Metrics

Explore detailed financial metrics and analysis for ENSC.